Select Page
Specialty drug markups lead to higher premiums

Specialty drug markups lead to higher premiums

A study commissioned by AHIP estimates that US commercial health insurance premiums jumped $13.1 billion this year due to provider markups on specialty drugs. An analysis of 2021 MarketScan commercial data found that the average costs of the top 10 specialty drugs by...